Repeat-dose steady-state pharmacokinetic evaluation of once-daily hydromorphone extended-release (OROS(®) hydromorphone ER) in patients with chronic pain
about
Drug Formulation Advances in Extended-Release Medications for Pain Control.Single-dose evaluation of safety, tolerability and pharmacokinetics of newly formulated hydromorphone immediate-release and hydrophilic matrix extended-release tablets in healthy Japanese subjects without co-administration of an opioid antagonist.
P2860
Repeat-dose steady-state pharmacokinetic evaluation of once-daily hydromorphone extended-release (OROS(®) hydromorphone ER) in patients with chronic pain
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh
2012年學術文章
@zh-hant
name
Repeat-dose steady-state pharm ...... in patients with chronic pain
@ast
Repeat-dose steady-state pharm ...... in patients with chronic pain
@en
type
label
Repeat-dose steady-state pharm ...... in patients with chronic pain
@ast
Repeat-dose steady-state pharm ...... in patients with chronic pain
@en
prefLabel
Repeat-dose steady-state pharm ...... in patients with chronic pain
@ast
Repeat-dose steady-state pharm ...... in patients with chronic pain
@en
P2093
P2860
P356
P1476
Repeat-dose steady-state pharm ...... in patients with chronic pain
@en
P2093
Henry M Richards
Joris Vandenbossche
Ute Richarz
P2860
P304
P356
10.2147/JPR.S33807
P577
2012-11-09T00:00:00Z